Anakin Chu Kwan Lai1,2, John C Buchan3, Jonathan Cheuk-Hung Chan4, Winifred Nolan3,5. 1. International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK. laianakinlai2@gmail.com. 2. Department of Ophthalmology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China. laianakinlai2@gmail.com. 3. International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK. 4. Department of Ophthalmology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China. 5. NIHR Biomedical Research Centre, Moorfields and UCL Institute of Ophthalmology, London, UK.
Abstract
BACKGROUND: Glaucoma is the commonest cause of irreversible blindness worldwide. As it is typically asymptomatic until advanced, the risk of blindness from late presentation is higher than other eye diseases. This study aims to investigate the risk factors for late presentation of primary glaucoma patients. METHODS: We undertook a hospital-based case-control study of a random sample of glaucoma patients from a hospital in Hong Kong. Structured questionnaires and existing information from the electronic patient record were used, and the odds of presenting late were analysed by logistic regression. RESULTS: Of 210 recruited participants, 83 (39.5%) presented with advanced glaucoma unilaterally or bilaterally. The mean age of participants was 61.1 ± 11.9 years, with 110 males (52.4%). Univariate analysis revealed that male sex and primary angle-closure glaucoma (PACG) have 3.06 (CI95:1.71-5.48; P < 0.001) and 2.47 (CI95:1.11-5.49; P = 0.03) times higher odds of late presentation, respectively. Multivariate analysis revealed late presenters were 3.54 (CI95:1.35-9.35; P = 0.01) times more likely to have PACG than primary open-angle glaucoma (POAG). Patients with elevated baseline intraocular pressure (IOP) also had 1.06 times higher odds of presenting with advanced glaucoma (CI95:1.02-1.11; P = 0.002). Linear regression revealed that PACG patients present with 7.12 mmHg higher IOP than POAG patients (CI95:4.23-10.0; P < 0.001). CONCLUSION: In conclusion, a high proportion of glaucoma patients present late in Hong Kong, with gender and type of glaucoma being significant determinants. Our study shows that PACG presents with higher IOP and, along with male gender, are more likely to have advanced disease than POAG.
BACKGROUND: Glaucoma is the commonest cause of irreversible blindness worldwide. As it is typically asymptomatic until advanced, the risk of blindness from late presentation is higher than other eye diseases. This study aims to investigate the risk factors for late presentation of primary glaucoma patients. METHODS: We undertook a hospital-based case-control study of a random sample of glaucoma patients from a hospital in Hong Kong. Structured questionnaires and existing information from the electronic patient record were used, and the odds of presenting late were analysed by logistic regression. RESULTS: Of 210 recruited participants, 83 (39.5%) presented with advanced glaucoma unilaterally or bilaterally. The mean age of participants was 61.1 ± 11.9 years, with 110 males (52.4%). Univariate analysis revealed that male sex and primary angle-closure glaucoma (PACG) have 3.06 (CI95:1.71-5.48; P < 0.001) and 2.47 (CI95:1.11-5.49; P = 0.03) times higher odds of late presentation, respectively. Multivariate analysis revealed late presenters were 3.54 (CI95:1.35-9.35; P = 0.01) times more likely to have PACG than primary open-angle glaucoma (POAG). Patients with elevated baseline intraocular pressure (IOP) also had 1.06 times higher odds of presenting with advanced glaucoma (CI95:1.02-1.11; P = 0.002). Linear regression revealed that PACG patients present with 7.12 mmHg higher IOP than POAG patients (CI95:4.23-10.0; P < 0.001). CONCLUSION: In conclusion, a high proportion of glaucoma patients present late in Hong Kong, with gender and type of glaucoma being significant determinants. Our study shows that PACG presents with higher IOP and, along with male gender, are more likely to have advanced disease than POAG.
Authors: Lisa A Hark; Jonathan S Myers; Andrew Ines; Alicia Jiang; Kamran Rahmatnejad; Tingting Zhan; Benjamin E Leiby; Sarah Hegarty; Scott J Fudemberg; Anand V Mantravadi; Michael Waisbourd; Jeffrey D Henderer; Christine Burns; Meskerem Divers; Jeanne Molineaux; Laura T Pizzi; Ann P Murchison; Jinan Saaddine; Louis R Pasquale; Julia A Haller; L Jay Katz Journal: Br J Ophthalmol Date: 2019-02-15 Impact factor: 4.638
Authors: Y Shiose; Y Kitazawa; S Tsukahara; T Akamatsu; K Mizokami; R Futa; H Katsushima; H Kosaki Journal: Jpn J Ophthalmol Date: 1991 Impact factor: 2.447
Authors: Sang Jin Seo; Yun Ha Lee; Sang Yeop Lee; Hyoung Won Bae; Samin Hong; Gong Je Seong; Chan Yun Kim Journal: J Ophthalmol Date: 2016-05-09 Impact factor: 1.909